← Back to directory

Laura Mauri

Researcher Next ID · RN-026764

Researcher · Medicine

University of Milan

Milan, Czechia

Not currently recruitingFunding unknown
Works count
519
Citation count
61,159
H-index
95
i10-index
290

Research interests

Medicine
Coronary Interventions and Diagnostics
Antiplatelet Therapy and Cardiovascular Diseases
Acute Myocardial Infarction Research
Cardiac Imaging and Diagnostics
Cardiac Valve Diseases and Treatments

Publications

  • Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

    The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)01787-1

  • Complete Revascularization with Multivessel PCI for Myocardial Infarction

    New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1907775

  • Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

    The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31082-1

  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    Circulation · 2018 · https://doi.org/10.1161/circulationaha.117.033502

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    European Heart Journal · 2017 · https://doi.org/10.1093/eurheartj/ehx419

  • 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischem

    Circulation · 2016 · 10.1161/cir.0000000000000404

  • Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

    JAMA · 2016 · https://doi.org/10.1001/jama.2016.3775

  • 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

    Journal of the American College of Cardiology · 2016 · 10.1016/j.jacc.2016.03.513

  • Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

    Journal of the American College of Cardiology · 2015 · https://doi.org/10.1016/j.jacc.2015.03.003

  • 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction

    Journal of the American College of Cardiology · 2015 · 10.1016/j.jacc.2015.10.005

  • Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis

    Heart · 2015 · https://doi.org/10.1136/heartjnl-2014-307119

  • A Controlled Trial of Renal Denervation for Resistant Hypertension

    New England Journal of Medicine · 2014 · 10.1056/nejmoa1402670

  • Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

    New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1409312

  • Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis

    The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)62052-3

  • Diagnostic Accuracy of Fractional Flow Reserve From Anatomic CT Angiography

    JAMA · 2012 · 10.1001/2012.jama.11274

  • Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation

    Circulation · 2009 · https://doi.org/10.1161/circulationaha.109.849885

  • Clinical End Points in Coronary Stent Trials

    Circulation · 2007 · 10.1161/circulationaha.106.685313

Current projects

    No projects listed.